Rhythm Pharmaceuticals EVP Mazabraud Sells $6.6M in Stock

Executive Vice President of Rhythm Pharmaceuticals (RYTM), Mazabraud, sold $6.6 million worth of stock. This transaction reflects a significant movement in the company's shares. Selling stock by executives can impact market perceptions of the company's outlook. It is important for investors to monitor such sales as they may signal internal confidence within the company.